The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality

被引:13
作者
Zhou, Yanling [1 ,2 ]
Wang, Chengyu [1 ,2 ]
Lan, Xiaofeng [1 ,2 ]
Zheng, Wei [1 ,2 ]
Li, Hanqiu [1 ,2 ]
Chao, Ziyuan [1 ,2 ]
Wu, Kai [1 ,2 ,3 ]
McIntyre, Roger S. [4 ,5 ,6 ,7 ,8 ,9 ]
Ning, Yuping [1 ,2 ,10 ]
机构
[1] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Peoples R China
[2] Guangdong Engn Technol Res Ctr Translat Med Menta, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Mat Sci & Engn, Dept Biomed Engn, Guangzhou, Peoples R China
[4] Canadian Rapid Treatment Ctr Excellence, Mississauga, ON, Canada
[5] Univ Hlth Network, Poul Hansen Depress Ctr, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[8] Brain & Cognit Discovery Fdn, Toronto, ON, Canada
[9] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[10] Southern Med Univ, Sch Clin Med 1, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Cognition; Ketamine; Depression; Treatment resistance; Suicidality; DOUBLE-BLIND; NEUROCOGNITIVE PERFORMANCE; FUNCTIONAL OUTCOMES; ANTIDEPRESSANT; EFFICACY; ASSOCIATION; ESKETAMINE; IMPAIRMENT;
D O I
10.1016/j.jpsychires.2021.10.037
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Ketamine has rapid and robust antidepressant effects in depression, while its effects on cognitive measures are less clearly understood. This aim of the study herein is to determine whether ketamine has direct pro-cognitive effects in real-world treatment depression and/or suicidality. Methods: Subjects with unipolar (n = 84) and bipolar (n = 27) depression suffering treatment resistance or suicidality received six infusions of ketamine (0.5 mg/kg) during a 12-day period. Depression symptoms were assessed using the Montgomery-Asberg Depression Rating Scale at baseline, day 13 and day 26. Cognitive domains, including processing speed, working memory, visual learning and verbal learning were also measured using the MATRICS Consensus Cognitive Battery at the same time-points. Results: Significant improvement was observed in processing speed at day 13 (effect size [ES] = 0.501) and day 26 (ES = 0.654), and verbal learning at day 13 (ES = 0.362). Path analysis showed significant direct (beta = 2.444, P = 0.017) and indirect (beta = 1.220, P = 0.048) effect of ketamine on processing speed, indicating its improvement was partly independent of improvement in depressive symptoms. The direct effect (beta = 1.963, P = 0.052) of ketamine on verbal learning was not significant, whereas the indirect effect (beta = 1.386, P = 0.024) was significant, indicating treatment with ketamine indirectly improved verbal learning performance, via changes in depressive symptom. Conclusion: Six infusions of ketamine have a potential mood independent pro-cognitive effect on processing speed in adults with treatment depression and/or suicidality. The potential pro-cognitive effects of ketamine provide the basis for hypothesizing that other clinical outcomes (e.g., suicidality, functional impairment) reported with ketamine treatment may be in part mediated by improvement in cognition.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 53 条
[31]   Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial [J].
Murrough, James W. ;
Losifescu, Dan V. ;
Chang, Lee C. ;
Al Jurdi, Rayan K. ;
Green, Charles E. ;
Perez, Andrew M. ;
Lqbal, Syed ;
Pillemer, Sarah ;
Foulkes, Alexandra ;
Shah, Asim ;
Charney, Dennis S. ;
Mathew, Sanjay J. .
AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10) :1134-1142
[32]   Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review [J].
Ng, Jason ;
Rosenblat, Joshua D. ;
Lui, Leanna M. W. ;
Teopiz, Kayla M. ;
Lee, Yena ;
Lipsitz, Orly ;
Mansur, Rodrigo B. ;
Rodrigues, Nelson B. ;
Nasri, Flora ;
Gill, Hartej ;
Cha, Danielle S. ;
Subramaniapillai, Mehala ;
Ho, Roger C. ;
Cao, Bing ;
McIntyre, Roger S. .
JOURNAL OF AFFECTIVE DISORDERS, 2021, 293 :285-294
[33]   Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study [J].
Popova, Vanina ;
Daly, Ella J. ;
Trivedi, Madhukar ;
Cooper, Kimberly ;
Lane, Rosanne ;
Lim, Pilar ;
Mazzucco, Christine ;
Hough, David ;
Thase, Michael E. ;
Shelton, Richard C. ;
Molero, Patricio ;
Vieta, Eduard ;
Bajbouj, Malek ;
Manji, Husseini ;
Drevets, Wayne C. ;
Singh, Jaskaran B. .
AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06) :428-438
[34]   Ketamine normalizes brain activity during emotionally valenced attentional processing in depression [J].
Reed, Jessica L. ;
Nugent, Allison C. ;
Furey, Maura L. ;
Szczepanik, Joanna E. ;
Evans, Jennifer W. ;
Zarate, Carlos A., Jr. .
NEUROIMAGE-CLINICAL, 2018, 20 :92-101
[35]   An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder [J].
Saligan, Leorey N. ;
Luckenbaugh, David A. ;
Slonena, Elizabeth E. ;
Machado-Vieira, Rodrigo ;
Zarate, Carlos A., Jr. .
JOURNAL OF AFFECTIVE DISORDERS, 2016, 194 :115-119
[36]   Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression [J].
Shiroma, Paulo R. ;
Thuras, Paul ;
Wels, Joseph ;
Albott, C. Sophia ;
Erbes, Christopher ;
Tye, Susannah ;
Lim, Kelvin O. .
JOURNAL OF AFFECTIVE DISORDERS, 2020, 277 :470-477
[37]   Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression [J].
Shiroma, Paulo R. ;
Albott, C. Sophia ;
Johns, Brian ;
Thuras, Paul ;
Wels, Joseph ;
Lim, Kelvin O. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (11) :1805-1813
[38]   A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression [J].
Singh, Jaskaran B. ;
Fedgchin, Maggie ;
Daly, Ella J. ;
De Boer, Peter ;
Cooper, Kimberly ;
Lim, Pilar ;
Pinter, Christine ;
Murrough, James W. ;
Sanacora, Gerard ;
Shelton, Richard C. ;
Kurian, Benji ;
Winokur, Andrew ;
Fava, Maurizio ;
Manji, Husseini ;
Drevets, Wayne C. ;
Van Nueten, Luc .
AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08) :816-826
[39]   Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials [J].
Tamura, Jocelyn K. ;
Carvalho, Isabelle P. ;
Leanna, Lui M. W. ;
Feng, Jia Nuo ;
Rosenblat, Joshua D. ;
Mansur, Rodrigo ;
Lee, Yena ;
Cha, Danielle S. ;
Teopiz, Kayla ;
Ahmad, Zara ;
Nasri, Flora ;
Kim, Jiin ;
McIntyre, Roger S. .
CNS SPECTRUMS, 2022, 27 (04) :399-420
[40]   The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis [J].
Wilkinson, Samuel T. ;
Ballard, Elizabeth D. ;
Bloch, Michael H. ;
Mathew, Sanjay J. ;
Murrough, James W. ;
Feder, Adriana ;
Sos, Peter ;
Wang, Gang ;
Zarate, Carlos A., Jr. ;
Sanacora, Gerard .
AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (02) :150-158